Integrated multi-omics analyses reveal the pro-inflammatory and pro-fibrotic pulmonary macrophage subcluster in

Hanyujie Kang1, Xueqing Gu1, Siyu Cao1

  • 1Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.

Abstract

Insights

This study identifies Mmp12-high macrophages as key drivers of silicosis progression by promoting inflammation and fibrosis. Targeting these specific macrophages offers a potential therapeutic strategy for this debilitating lung disease.

Area of Science:

  • Pulmonary immunology
  • Occupational lung diseases
  • Fibrosis research

Background:

  • Silicosis is a severe occupational lung disease caused by silica dust inhalation.
  • Pulmonary macrophages are critical in silicosis initiation, but their heterogeneity is poorly understood.

Purpose of the Study:

  • To investigate the phenotypic and functional heterogeneity of pulmonary macrophages in silicosis.
  • To identify specific macrophage subsets involved in silicosis pathogenesis.
  • To explore potential therapeutic targets for silicosis.

Main Methods:

  • Established a silicosis mouse model via silica suspension instillation.
  • Analyzed bronchoalveolar lavage fluids (BALFs) for cytokine levels.
  • Utilized single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics to characterize lung macrophages.
  • Assessed lung fibrosis through histology, hydroxyproline assay, and immunohistochemistry.
  • Quantified gene expression of inflammatory and fibrotic markers using qPCR.

Main Results:

  • Silicotic mice exhibited elevated pro-inflammatory cytokines and chemokines in BALFs and significant collagen deposition.
  • scRNA-seq identified an expansion of Mmp12-high macrophages in silicotic lungs.
  • Spatial transcriptomics localized Mmp12-high macrophages within fibrotic nodules.
  • These macrophages, derived from Ly6c+ monocytes, express high levels of pro-inflammatory and pro-fibrotic genes.
  • Treatment with 4-octyl itaconate (4-OI) reduced Mmp12-high macrophage enrichment and alleviated pulmonary fibrosis.
  • Macrophages from human silicosis patients showed similar Mmp12-high characteristics.

Conclusions:

  • Mmp12-high macrophages are a distinct subset in silicosis, expressing pro-inflammatory and pro-fibrotic factors that drive disease progression.
  • These findings illuminate lung macrophage heterogeneity in silicosis.
  • Mmp12-high macrophages represent a promising therapeutic target for halting silicosis progression.